UC-CARE

Prostate Disease Diagnosis and Treatment

Health Tech & Life Sciences
Active
Mature Yokne'am Illit, Israel Founded 2004
Last updated 2026-06-18
Total raised
$1.6M
Last: 2019-03
Stage
Mature
Founded
2004
Headcount
17
HQ
Yokne'am Illit, Israel
Sector
Health Tech & Life Sciences

About

UC-CARE has developed a patented diagnostic and treatment system designed to improve procedures for prostate diseases. The system aims to solve the problem of blind biopsies and to provide an improved system for focal treatment.

Navigo is a device that allows physicians to image, plan, place, and record prostate biopsy samples in high-resolution 3D, allowing them to more confidently sample precise areas of the prostate and record biopsy locations for future reference.

Navigo Viewer is a CD given to patients upon completion of the procedure. It enables patients and the referring physician to view the procedure summary and keep a record for future follow-ups.

SmartBx is a biopsy core preservation and management system that is designed to seamlessly integrate into the TRUS biopsy procedure and contribute to a high cancer-detection rate and improved cancer management, especially for active surveillance processes.

Navigo Fusion Studio is a software solution for fusion planning. Its automated algorithms allow radiologists and urologists to quickly prepare images to be processed by Navigo. Cases are automatically sent to the Navigo workstation, streamlining the process from planning to procedure.

Funding history · 2 rounds · $1.6M total

2019-03

Q&A

What is UC-CARE's primary focus?
UC-CARE specializes in the diagnosis and treatment of prostate diseases, developing patented systems to improve procedures.
When was UC-CARE founded?
UC-CARE was founded in June 2004.
What is the total amount of funding UC-CARE has raised to date?
UC-CARE has raised a total of $1,560,000 USD.
When was UC-CARE's most recent funding round and who invested?
UC-CARE's most recent funding round was in March 2019, with an investment from Florida Funders.
What is Navigo?
Navigo is a device developed by UC-CARE that enables physicians to image, plan, place, and record prostate biopsy samples in high-resolution 3D.
What is SmartBx?
SmartBx is a biopsy core preservation and management system from UC-CARE designed to integrate into the TRUS biopsy procedure for improved cancer detection and management.
Where is UC-CARE's headquarters located?
UC-CARE's headquarters is located in Yokne'am Illit, Israel.

Team · 1

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesMedical Treatment & Therapeutics
Technologies
Platforms & InterfacesSoftwareSimulation & Imaging
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2B

Highlights

1 Patents

Tags

doctorsimagingbiopsyoncologycancermedical-technologiesdiagnosticsmedical-devices3d-technologyhospitalspatientsurologysoftware-developmentoptronicstreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)